G9a-dependent gene expression in mouse AML cells
收藏官方服务：
资源简介：
G9a-dependent gene expression in mouse AML cells
应用场景：
创建时间：
2014-01-08
相关数据集
Table 5_Local Promoter Methylation Disorder algorithm reveals bidirectional epigenetic disruption in DNMT3A-mutated AML and predicts azacitidine treatment response.xlsx
BackgroundDNMT3A mutations occur in 20-25% of acute myeloid leukemia (AML) cases and are associated with poor prognosis, yet the epigenetic mechanisms underlying treatment response remain poorly under
NIAID Data Ecosystem80
Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia
The FDA-approved DNA hypomethylating agents (DHAs) like 5-azacytidine (5AC) and decitabine (DAC) demonstrate efficacy in the treatment of hematologic malignancies. Despite previous reports that showed
NIAID Data Ecosystem40
Interplay between CoREST, p300 and retinoic acid signaling in Acute myeloid leukemia [RNA-seq]
The histone demethylase KDM1A (LSD1), a component of the CoREST corepressor complex, is highly expressed in hematologic malignancies and regulates hematopoietic differentiation. Despite its essential
NIAID Data Ecosystem20
H3K9 acetylation and di-methylation changes in HL-60 cells following treatment with different compounds. H3K9 acetylation and di-methylation changes in HL-60 cells following treatment with different compounds
We investigate the effects of GCN5 and LSD1 inhibition in acute myeloid leukemia. Therefore, we characterized acetylation and di-methylation changes by ChIP-seq in AML cells (AML M2 cell line HL-60) f
NIAID Data Ecosystem50
Supplementary Table 7 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
GO Analysis from Regions of Differential MOLM13 H3K27Ac CUT&Tag (6 Hours After Drug Treatment) Pileup at Enhancers and Promoters
NIAID Data Ecosystem30
